Dow's Nearly 725-Point Rally Highlighted By Gains In NVIDIA Corp., Amgen Stocks

Dow Jones03:51

DJ Dow's Nearly 725-Point Rally Highlighted By Gains In NVIDIA Corp., Amgen Stocks

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of NVIDIA Corp. and Amgen are trading higher Wednesday afternoon, propelling the Dow Jones Industrial Average rally.

Shares of NVIDIA Corp. (NVIDIA Corp.) and Amgen (Amgen Inc.) are contributing about a quarter of the index's intraday rally, as the Dow (Dow Jones Industrial Average) was most recently trading 720 points higher (1.5%).

NVIDIA Corp.'s shares have risen $6.84, or 3.8%, while those of Amgen are up $11.89, or 3.6%, combining for an approximately 115-point boost for the Dow.

Sherwin-Williams Co. (Sherwin-Williams Co.), American Express (American Express Co.), and UnitedHealth (UnitedHealth Group Inc.) are also contributing significantly to the gain.

A $1 move in any of the benchmark's 30 components equates to a 6.16-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled January 21, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

January 21, 2026 14:51 ET (19:51 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment